• NAT1–ENO1–Lactate Signaling in Colorectal Cancer

  2026-09-23

  A 2026 MedComm study describes how NAT1 restrains ENO1-driven glycolysis and lactate production, while lactate promotes TRAF6-dependent stabilization of PD-L1 in colorectal cancer. Patient and mouse-model findings connect this metabolic pathway to checkpoint-blockade response and provide a mechanistic basis for further preclinical investigation.

• Tranexamic Acid for Fibrinolysis Research

  2026-09-23

  Use Tranexamic Acid as a mechanistic probe for clot stability, plasmin biology, and advanced hemostatic materials. This workflow connects concentration-controlled biochemical assays with the bi-layer dressing strategy reported for rapid clot formation and antibacterial wound protection.

• Cy7 NHS Ester: Practical Labeling Guide

  2026-09-22

  Cy7 NHS ester (SKU A8109) is a water-compatible amino-group labeling reagent for preparing near-infrared fluorescent biomolecule conjugates, including protein and peptide conjugates. It is best suited to targets with accessible primary amines and workflows that use freshly prepared reagent solutions; it is not appropriate for amine-free targets or long-term storage of prepared solutions.

• LDH Cytotoxicity Assay Kit: Practical Guide

  2026-09-22

  The LDH Cytotoxicity Assay Kit provides a non-radioactive method for cell cytotoxicity measurement by detecting LDH released after loss of plasma-membrane integrity. It is appropriate for comparative cell damage quantification, but LDH release alone should not be used to identify apoptosis, distinguish death pathways, or replace interference and viability controls.

• MLN8237 (Alisertib): A Translational Aurora A Strategy

  2026-09-21

  Aurora kinase A is emerging as a mechanistically grounded vulnerability in aggressive cancers, including retinoblastoma. This thought-leadership article connects the biology of AURKA–MYCN signaling with the selective pharmacology of MLN8237 (Alisertib), outlining practical workflows, translational safeguards, and the evidence needed to move from target expression to actionable response.

• DNA Frameworks Improve Enzymatic Oligonucleotide Synthesis

  2026-09-21

  Li and colleagues developed a tetrahedral DNA nanostructure interface that organizes primers for more accessible enzymatic oligonucleotide synthesis. The framework improved substrate interaction, reaction kinetics, sequence yield, and information recovery, while also defining important limits for translating the approach to fluorescent DNA-labeling workflows.

• Nigericin Sodium Salt: Protocol and QC Guide

  2026-09-20

  Nigericin sodium salt is a potassium ionophore for controlled studies of K+/H+ exchange, membrane ion gradients, cytoplasmic pH regulation, and related assay readouts. This guide covers preparation, controls, and failure analysis for research workflows; it should not be used for diagnosis, treatment, or unvalidated clinical applications.

• Metal-Ion Enrichment Improves mRNA Vaccine Design

  2026-09-19

  The reference study introduces a manganese-mediated condensation strategy that creates a dense mRNA core before lipid coating, increasing payload loading and cellular uptake relative to conventional LNP-mRNA formulations. Its findings support a dose-sparing vaccine design principle, while also highlighting the need to validate metal-ion composition, lipid architecture, immune effects, and mRNA chemistry across models.

• ZCL278: A Selective Cdc42 Inhibitor Workflow

  2026-09-18

  ZCL278 enables time-resolved control of Cdc42 signaling in motility, neuronal morphology, and fibroblast assays. This practical guide connects target-engagement measurements with imaging and viability endpoints while separating established product evidence from exploratory fibrosis applications.

• Polybrene: Designing Cleaner p53 Reactivation Assays

  2026-09-18

  Polybrene and Hexadimethrine Bromide can improve gene-delivery consistency, but their greatest value in mutant-p53 research lies in controlling assay variability. This article connects Polybrene-mediated delivery design with the chemically induced proximity mechanism reported for TRAP-1, while separating delivery effects from genuine p53 reactivation.

• Simvastatin (Zocor) Research Workflows

  2026-09-17

  Build reproducible Simvastatin (Zocor) workflows for lipid metabolism, hepatic cancer, and hyperlipidemia models. This guide connects formulation control with apoptosis, lipid-accumulation, and lipidomics readouts while highlighting practical troubleshooting decisions.

• HIV-1 Signalling and Nuclear Pore Remodelling

  2026-09-17

  The reference study identifies nuclear import through the nuclear pore complex as a decisive barrier to HIV-1 infection of resting CD4+ T cells. It shows that cell–cell spread activates CD4–LCK–CDK1 signalling, remodels nucleoporins, and licenses capsid entry into the nucleus without requiring conventional cell-cycle entry.

• Deferasirox Review: Evidence for Oral Iron Chelation

  2026-09-16

  This formulary review established deferasirox as an oral tridentate chelator and evaluated its pharmacology, comparative efficacy, tolerability, adherence implications, and economic context. Its central practical finding was that oral treatment could provide a clinically meaningful alternative to demanding deferoxamine infusions for transfusion-related iron overload, while safety and organ-specific iron mobilization remained important considerations.

• Oteseconazole (VT-1161) Assay Guide

  2026-09-16

  A scenario-based laboratory guide to using Oteseconazole (VT-1161), SKU BA1665, in Candida susceptibility, viability, and cytotoxicity workflows. It connects CYP51 mechanism, concentration selection, solvent controls, resistance-aware interpretation, and practical product-selection criteria to improve assay clarity.

• 2',7'-Dichlorofluorescein diacetate for ROS Assays

  2026-09-15

  Build more reproducible intracellular ROS measurements with a practical workflow for cancer, toxicology, and drug-discovery studies. The guide also shows how to use this general redox indicator to interrogate ROS-responsive nanocarriers without overinterpreting DCF fluorescence as a species-specific measurement.

8484 records 1/566 page Next 12345 下5页 Last page